Profile data is unavailable for this security.
About the company
Median Technologies SA is a France-based company that publishes software for the diagnosis and monitoring of cancer patients. The Company develops lesion management solutions (LMS) to objectively measure and track cancerous or suspicious lesions, distribute a standardized oncologic report and centralize the lesion information for multidisciplinary review. The LMS line includes such products as LMS-Lung, a clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest; LMS-Track, a clinical application for the follow-up of oncology patients; and LMS-Liver, a clinical application for the initial evaluation and the follow-up of liver metastases and any other lesions identified in CT images covering the liver. The Company operates one subsidiary, Median Technologies Inc, based in the United States.
- Revenue in EUR (TTM)21.84m
- Net income in EUR-25.35m
- Incorporated2002
- Employees250.00
- LocationMedian Technologies SALes Deux Arcs - Batiment B 1800Route des CretesVALBONNE 06560FranceFRA
- Phone+33 493333777
- Fax+33 492906599
- Websitehttps://mediantechnologies.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnostic Medical Systems SA | 44.21m | -14.97m | 15.20m | 143.00 | -- | 1.22 | -- | 0.3439 | -0.7915 | -0.5415 | 2.50 | 0.6862 | 0.8833 | 1.90 | 4.93 | 300,761.90 | -30.18 | -12.33 | -57.32 | -22.14 | 38.00 | 37.72 | -34.17 | -16.45 | 0.6439 | -6.43 | 0.5991 | -- | 19.51 | 11.62 | -106.30 | -- | -- | -- |
| Ikonisys SA | 448.56k | -2.27m | 16.03m | 10.00 | -- | 0.8913 | -- | 35.73 | -0.233 | -0.233 | 0.0461 | 1.62 | 0.0211 | 1.18 | 32.21 | 44,856.00 | -10.65 | -- | -12.50 | -- | -20.88 | -- | -505.54 | -- | 0.0619 | -29.68 | 0.1244 | -- | -27.28 | -- | 7.38 | -- | -- | -- |
| Mauna Kea Technologies SA | 7.54m | -11.21m | 16.75m | 65.00 | -- | -- | -- | 2.22 | -0.2155 | -0.2155 | 0.1456 | -0.3148 | 0.3556 | 1.99 | 4.10 | 110,823.50 | -56.61 | -51.23 | -142.92 | -93.30 | 11.48 | 11.15 | -159.20 | -142.41 | 0.6603 | -12.87 | 3.50 | -- | 40.13 | 9.16 | 66.66 | -- | -21.16 | -- |
| Global Bioenergies SA | 486.06k | -7.36m | 17.05m | 45.00 | -- | 3.69 | -- | 35.08 | -0.4036 | -0.4036 | 0.0267 | 0.255 | 0.0276 | 5.06 | 0.4599 | 10,566.52 | -41.78 | -43.66 | -60.78 | -82.47 | -1,192.39 | -948.35 | -1,514.49 | -1,331.36 | 2.79 | -- | 0.5044 | -- | 365.83 | 36.25 | 27.78 | -- | -19.49 | -- |
| Theraclion SA | 1.28m | -3.56m | 17.28m | 28.00 | -- | 5.22 | -- | 13.47 | -0.0769 | -0.0769 | 0.0275 | 0.0719 | 0.0718 | -0.0103 | 1.03 | 44,235.86 | -19.94 | -32.98 | -26.41 | -48.01 | 102.48 | 60.85 | -277.68 | -249.16 | 2.69 | -- | 0.3303 | -- | 47.49 | -1.13 | 25.97 | -- | -7.23 | -- |
| Biosynex SA | 104.03m | -38.63m | 29.70m | 521.00 | -- | 0.2792 | -- | 0.2855 | -3.70 | -3.70 | 9.96 | 9.89 | 0.4326 | 0.5978 | 7.67 | 180,913.00 | -16.08 | 14.90 | -27.57 | 19.41 | 24.67 | 51.92 | -37.18 | 14.61 | 0.4005 | -12.58 | 0.3783 | -- | -52.70 | 24.40 | -337.76 | -- | -- | -- |
| AbL Diagnostics SA | 5.61m | 54.36k | 45.77m | 19.00 | 842.73 | 6.76 | 63.87 | 8.15 | 0.0034 | 0.0034 | 0.3483 | 0.42 | 0.3703 | -- | 1.42 | 295,411.60 | 0.3587 | 3.24 | 0.5884 | 4.43 | -- | -- | 0.9685 | 8.81 | 1.87 | -47.51 | 0.3389 | -- | -35.84 | 74.86 | -95.08 | -49.30 | -- | -- |
| Carmat SA | 5.53m | -53.35m | 57.41m | 162.00 | -- | -- | -- | 10.38 | -1.76 | -1.76 | 0.1787 | -0.6419 | 0.0932 | 1.61 | 1.28 | 30,379.12 | -89.92 | -76.92 | -113.71 | -94.38 | -535.50 | -- | -964.91 | -4,636.64 | 1.69 | -17.37 | 1.63 | -- | 710.72 | -- | -0.3502 | -- | 16.99 | -- |
| Affluent Medical SAS | 0.00 | -17.04m | 72.58m | 66.00 | -- | 2.35 | -- | -- | -0.5338 | -0.5338 | 0.00 | 0.7864 | 0.00 | -- | -- | 0.00 | -28.43 | -- | -34.69 | -- | -- | -- | -- | -- | -- | -24.62 | 0.3586 | -- | -- | -- | -2.80 | -- | -- | -- |
| Median Technologies SA | 21.84m | -25.35m | 75.92m | 250.00 | -- | -- | -- | 3.48 | -1.29 | -1.29 | 1.11 | -1.19 | 0.7873 | -30.31 | 3.57 | 90,227.27 | -91.41 | -54.57 | -- | -157.51 | 105.00 | 101.57 | -116.10 | -93.70 | 0.6879 | -138.58 | 4.77 | -- | -6.10 | 28.52 | -13.70 | -- | 38.38 | -- |
| Amplitude Surgical SA | 106.02m | 1.53m | 151.75m | 428.00 | 99.31 | 1.58 | 10.84 | 1.43 | 0.0318 | 0.0318 | 2.21 | 2.00 | 0.3889 | 0.5387 | 8.20 | 247,707.90 | 0.5605 | 0.4412 | 0.6687 | 0.52 | 79.36 | 77.84 | 1.44 | 1.28 | 1.09 | 0.6959 | 0.5503 | -- | 5.81 | 0.6658 | -96.11 | -- | 2.62 | -- |
| Lumibird SA | 203.56m | 7.13m | 157.27m | 1.05k | 19.67 | 0.812 | 6.43 | 0.7726 | 0.3559 | 0.3559 | 9.14 | 8.62 | 0.5238 | 1.09 | 4.05 | 193,497.10 | 1.83 | 3.13 | 2.44 | 3.99 | 61.68 | 61.76 | 3.50 | 5.89 | 1.62 | 2.47 | 0.4287 | 0.00 | 6.60 | 15.12 | -37.23 | -2.47 | 18.34 | -- |
Data as of Nov 08 2024. Currency figures normalised to Median Technologies SA's reporting currency: Euro EUR
13.65%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Herald Investment Management Ltd.as of 31 Dec 2023 | 522.35k | 2.84% |
| Aguja Capital GmbHas of 30 Jun 2023 | 512.69k | 2.78% |
| Apo Asset Management GmbHas of 30 Apr 2024 | 477.24k | 2.59% |
| Financi�re Arbevel SAas of 30 Dec 2022 | 401.15k | 2.18% |
| Discover Capital GmbHas of 30 Jun 2024 | 175.00k | 0.95% |
| Groupama Asset Management SAas of 31 Jul 2024 | 121.79k | 0.66% |
| Mandarine Gestion SAas of 29 Feb 2024 | 115.00k | 0.62% |
| Pure Capital SAas of 31 Dec 2023 | 68.29k | 0.37% |
| G�n�rali Investments Partners SpA SGR (France)as of 28 Feb 2022 | 65.00k | 0.35% |
| Hermitage Gestion Priv�e SAas of 29 Dec 2023 | 56.71k | 0.31% |
More ▼
Data from 30 Jun 2023 - 30 Sep 2024Source: FactSet Research Systems Inc.
